Objective: Inadequate cortisol levels and adrenal dysfunction may play a role in the pathophysiology of severe acute pancreatitis. This study aimed to analyse the incidence of relative adrenal insufficiency (RAI) in these patients, to identify factors associated with RAI and to describe how adrenal responsiveness affects outcome. Design: Prospective observational multicenter study. Patients: Twenty-five patients with severe acute pancreatitis. Interventions: A short Synacthen test (SST) was performed within 5 days after admission to the hospital. The incidence of RAI, defined as an increment after SST of less than 9 µg/dl was the primary endpoint of the study. Serum cortisol was measured at baseline and at 30 and 60 min after administration of 250 µg adrenocorticotropic hormone. Measurements and results: Median baseline cortisol level was 26.6 µg/dl, and increased to 43.2 µg/dl and 48.8 µg/dl after 30 min and 60 min respectively. RAI was found in 16% of all patients and in 27% of patients with organ dysfunction. Patients with RAI were more severely ill and had higher SOFA scores from days 4 to 7 after admission. All patients with RAI developed pancreatic necrosis, and all of them needed surgical interven-tion. Twenty-eight-day mortality was significantly higher in patients with RAI (75% vs. 5%, p = 0.007). Patients who died had a lower increment in cortisol levels after the SST than patients who survived. Conclusion: RAI is frequent in patients with severe acute pancreatitis and organ dysfunction. It occurs in patients with more severe pancreatitis and is associated with increased mortality.
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Introduction
Although necrosis and infection of necrosis remain the most feared complications in patients with severe acute pancreatitis (SAP), the importance of organ dysfunction as a risk factor for mortality is increasingly recognized [1] [2] [3] . Mortality in SAP occurs either early, due to an overwhelming systemic inflammatory response syndrome (SIRS) or late, owing to sepsis-related complications primarily arising from infected pancreatic necrosis. Patients who develop organ dysfunction early in the course of the disease have been identified as a subgroup within the whole group of SAP patients, and seem to be at particular risk of death; because of the clinical impact of organ dysfunction, and the associated high mortality rate, this clinical entity has been named early SAP. To date, it is unclear why fulminant organ dysfunction occurs in these patients [2] .
The clinical course of patients with SAP has many similarities with the clinical course of patients with severe sepsis and septic shock. They are both characterized by a systemic inflammatory response, and may lead to single or multiple organ failure [4] .
In recent years, relative adrenal insufficiency (RAI) has been recognized as an important problem in patients with severe sepsis and septic shock, acute hepatic dysfunction [5] , and after cardiopulmonary arrest [6] and several other diseases. In patients with septic shock, Annane and Bellissant found that an impaired response to a short Synacthen test (SST) was associated with increased mortality [7] , and subsequently Annane et al. reported that patients with an impaired adrenal response to corticotropic hormone had improved survival when treated with hydrocortisone and fludrocortisone [8] .
There is some evidence that steroids may also play a role in the pathophysiology of SAP [9] [10] [11] , but the responsiveness of the adrenal gland has not been investigated. The aim of this multicentre study was to study the incidence of RAI early in the course of the disease of patients with SAP and to investigate the correlation of adrenal dysfunction with outcome.
Material and methods
In a multicentre observational cohort study in one university and five non-university hospitals in Belgium, we prospectively studied adult patients (age ≥ 18 years at the time of presentation) with SAP who were admitted to one of the participating hospitals between March 2003 and October 2005.
SAP was defined according to the Atlanta criteria [12] . Patients were considered eligible for the study when one or more of the following were present: (1) failure of one or more organs (systolic blood pressure < 90 mmHg, paO 2 < 60 mmHg or serum creatinine > 2 mg/dl); (2) a Ranson score of 3 or higher; (3) an Acute Physiology and Chronic Health Evaluation (APACHE) II score [13] of 8 or higher; (4) local complication such as necrosis, abscess or pseudocyst. Patient who suffered prior attacks of acute pancreatitis, patients with systemic corticoid use in the preceding 3 months and those with known allergy to adrenocorticotropic hormone (ACTH) were excluded from the study.
In these patients, an SST was performed within the first 5 days after admission. Blood samples were collected prior to administration of 250 µg of ACTH (Synacthen ® ; Novartis Pharma, Vilvoorde, Belgium) (baseline), and at 30 and 60 min after IV administration of ACTH. Total cortisol was measured using an Immulite 2000 analyser (Diagnostic Products Corp., Belgium). Maximum cortisol was defined as the highest value after ACTH administration, the increment at 30 or 60 min was defined as the total cortisol level after 30 or 60 min minus the baseline level [8] . The need for mechanical ventilation and vasoactive medication at the time of the SST was recorded.
Baseline data collected included age, sex, aetiology, C-reactive protein (CRP) level at presentation and after 48 h, the Ranson score, the APACHE II score, the development of pancreatic necrosis and the need for surgery during the course of the disease. The occurrence rate of organ dysfunction was recorded and defined as follows [based on a score of 2 or more in the Sequential Organ Failure Assessment (SOFA) scoring system]: (1) cardiovascular: hypotension requiring vasoactive medication (epinephrine, norepinephrine, dobutamine at any dose, or dopamine at doses above 2 µg/kg/min); (2) renal: serum creatinine above 2.0 mg/dl; (3) pulmonary: the need for mechanical ventilation or a PaO 2 /FiO 2 ratio < 300. Organ dysfunction on days 1-7 after admission was assessed by the SOFA score.
Mortality was defined as 28-day mortality. Patients were considered normal responders to the SST when the increment in total cortisol levels after SST was greater than 9 µg/dl, as proposed by Annane et al. [8] . When the difference was less than 9 µg/dl, patients were defined as suffering from RAI.
Statistical analysis was performed using SPSS for Windows 12.0 ® (SPSS, Chicago, IL, USA). Results are expressed as the median (interquartile range), unless mentioned otherwise. Continuous variables were compared using the Mann-Whitney U-test. Categorical data were compared using the chi-square test or Fisher's exact test. A double-sided p-value of less than 0.05 was considered statistically significant.
This study was approved by the ethics committee of Ghent University Hospital and all participating hospitals. Signed informed consent was obtained from the patient, or from the next of kin when the patient was incapacitated.
Results

Patient characteristics
Twenty-five patients with a median age of 53 years (range 42-66 years) were included in the analysis. The main causes of pancreatitis were alcohol abuse (n = 10, 40%) and biliary tract stones (n = 8, 32%). Median amylase and lipase levels on admission were 649 IU/l (range 433-1029) and 1893 IU/l (range 733-3234) respectively. The median Ranson score was 6 (range 4-8), and the median APACHE II score was 14 (range [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Twenty-three patients (92%) were admitted to an intensive care unit or a high-dependency unit. The incidence of organ failure during the episode of pancreatitis was high: pulmonary dysfunction developed in 13 patients, cardiovascular dysfunction in 14, and renal dysfunction in 7 patients.
Pancreatic necrosis was demonstrated in 15 patients, and 8 patients needed surgical treatment because of suspected or proven infected necrosis (n = 6) or abdominal compartment syndrome (n = 2). Patients stayed in the hospital for a median of 27 days (range 17-60).
Patient condition at time of SST
The SST was performed after a median of 3 days (range 2-4) after admission to the hospital, and a median of 4 days (range 3-5) after the start of symptoms. The median SOFA score at the day of the SST was 5 (range 2-9). At the time of the SST, 10 patients were on mechanical ventilation and 7 required vasoactive medication because of hypotension.
Response to the SST Median baseline total cortisol level was 26.6 µg/dl, and increased to 43.2 µg/dl and 48.8 µg/dl after 30 and 60 min respectively ( Table 1 ). In patients who developed single or multiple organ dysfunction, maximum cortisol levels after SST were significantly lower than in patients without organ dysfunction [42.8 µg/dl (range 32.8-55.8) vs. 57.3 µg/dl (range 48.0-79.2); p = 0.04]. In patients who developed pancreatic necrosis, cortisol levels both at baseline and after the SST were not significantly different from those in patients who did not develop pancreatic necrosis.
Patients with RAI
In 4 out of 25 patients (16%), RAI was present. When only patients with organ dysfunction or pancreatic necrosis are considered, the occurrence rate increased to 27% (4/15 patients for each category). In patients with RAI, cortisol levels ranged from 14.3 to 55.8 µg/dl at baseline, RAI patients were more severely ill, as evidenced by a higher Ranson score and a higher APACHE II score on the day of the SST (Table 2) . Also, there was a trend towards a higher SOFA score. Although not different in the first few days, the SOFA score from day 4 to day 7 was significantly higher in patients with RAI than in patients with normal adrenal function ( Fig. 1 ). All patients with RAI developed pancreatic necrosis. All of them needed surgical intervention, two because of abdominal compartment syndrome and two because of infected pancreatic necrosis later in the course of the disease.
Twenty-eight-day mortality in patients with abnormal adrenal function was 75% (three of four patients), versus 5% in the patients without impaired adrenal function (p = 0.007). The three patients who died in the RAI group died on the 2nd, 13th and 28th day after admission. All of them had undergone surgery; the indication was suspected infection of the pancreatic and peripancreatic tissue in the first patient (which turned out to be sterile), and confirmed infected pancreatic necrosis in the other two.
In-hospital mortality was not different (75% vs. 24%, p = 0.08), as four patients in the non-RAI group died later than 28 days after admission. Three patients died of re- Table 3 Factors associated with 28-day mortality in patients with severe acute pancreatitis current infectious problems with associated organ dysfunction, on the 75th, 124th and 242nd day after admission. In another case, an elderly patient, therapy was withdrawn 3 months after the start of symptoms because of recurrent respiratory insufficiency due to a respiratory tract infection.
Patient outcome and relation to cortisol levels
Twenty-eight-day mortality in the study group was 16% (4/25). Patients who died had a higher Ranson score, and APACHE II score (Table 3 ). Also, their degree of organ dysfunction was higher at the time of the SST, as well as their maximal SOFA score. Absolute cortisol levels at T0, T30 and T60 were not different in patients who died, but the increment in cortisol level between baseline and 60 min after SST was significantly lower in patients who died [5.9 µg/dl (0.1-12.7) vs. 24.1 (15.2-36.4) , p = 0.009]. RAI occurred in 75% of the patients who died, against 5% in the patients who survived (p = 0.007).
Discussion
We found that RAI occurred in 16% of patients with SAP, in 27% of patients with SAP and organ dysfunction, and in 27% of patients with pancreatic necrosis. Patients with RAI were more severely ill, had higher organ dysfunction scores and had an increased risk for mortality.
Historically, there has been limited interest in the role of the adrenal gland in pancreatitis, and the role of corticosteroid treatment in acute pancreatitis has only recently gained some interest. The role of corticosteroids has been studied most extensively in animal models. Kimura et al. found in a caerulin model of acute pancreatitis that inflammation is more severe and mortality is increased in adrenalectomized rats [14] . Administration of corticosteroids reversed the observed increase in severity of pancreatitis and mortality, which demonstrated the role of both normal adrenals and endogenous corticosteroids in acute pancreatitis. The role of exogenous administered corticosteroids was also investigated by Osman et al., who reported that pre-treatment with steroids attenuated inflammation and improved survival in a rabbit model of acute pancreatitis [15] . Gloor et al. found a similar effect of corticosteroids (10 mg/kg hydrocortisone) on inflammation and outcome, also after induction of pancreatitis in an rat model [16] . Others found similar effects of other doses of corticosteroids [17] .
In patients with SAP, the role of adrenal failure is relatively unexplored. Previously, we observed a clinical picture in patients with SAP that had a number of similarities with the concept of RAI in patients with septic shock [11] . Recently, Muller et al. further provided insight into the potential role of the adrenal gland in the disease process [9] . In their study, they found that cortisol levels are higher in patients with severe disease than in patients with the mild, transient form of pancreatitis. The same was observed in patients with necrotizing disease, while in patients without pancreatic necrosis, cortisol level was low. Cortisol levels in patients with SAP were highest on day 1 after the start of symptoms and decreased progressively from day 1 to day 5. Over the same period of time, however, ACTH levels increased, which led the authors to conclude that exhaustion of the adrenal gland could be present. The only human data on the use of exogenous corticosteroids in patients with SAP were reported by Eklund et al. [10] . In a case-control study, they suggested that patients with acute pancreatitis and catecholamine-dependent shock who were treated with hydrocortisone were weaned from these drugs more quickly and the overall norepinephrine requirement in these patients was lower.
Our study confirm the findings by Muller et al. that baseline cortisol levels in patients with severe acute pancreatitis are high [9] . In their study, mean total cortisol levels in patients with SAP ranged between 20 and 30 µg/dl, which corresponds with the 26.2 µg/dl median we found in our patients. However, we could not demonstrate the presence of early RAI in the majority of the patients, at least when defined according to the definition proposed by Annane et al. in patients with septic shock.
We found in RAI in 16% of all patients with SAP and in 27% of the most severely ill patients, the subgroups of patients with pancreatic necrosis and of those with organ dysfunction. Also, we found that in patients with single or multiple organ dysfunction, total cortisol levels after SST were lower than in patients without organ dysfunction. All patients who were diagnosed with RAI had multiple organ dysfunction, and in these patients, SOFA scores were higher from day 3 onward. Patients with early and persistent organ dysfunction have been described in the past as suffering from early SAP. These patients have a very high mortality rate, and the clinical picture that is present often resembles that of severe sepsis and septic shock with rapidly progressive organ dysfunction. Also, patients who died had a lower increment in total cortisol than patients who survived.
This finding suggests that an impaired antiinflammatory response may be involved in patients who develop early multiple organ dysfunction syndrome, and that there might be a role for exogenous corticosteroids as anti-inflammatory agents [18] . Patients who develop early multiple organ dysfunction syndrome may well be a subgroup in whom RAI is more relevant than in others, and on the basis of our data, these patients should especially be considered when the therapeutic potential of corticosteroids in SAP is studied.
An impaired anti-inflammatory response has also been suggested to be an important step in patients with necrotizing disease. Cortisol may play a role in the development of pancreatic necrosis, as there is experimental evidence that it prevents cell apoptosis [14] . Consequently, low cortisol levels and RAI may actually promote pancreatic necrosis [19] . In the study by Muller, cortisol levels in patients with necrotizing disease were higher than in patients without necrosis, but a sharp decrease in concentrations was observed over the following days [9] . Although levels remained elevated, the concentrations may well be insufficient to counterbalance the overwhelming proinflammatory reaction in patients with SAP. In this regard, it is remarkable in our study that in patients who developed pancreatic necrosis, cortisol levels after SST were lower than in patients without pancreatic necrosis, although one would expect these patients to be more severely stressed and consequently have higher cortisol levels. In our study, all patients with RAI developed pancreatic necrosis, but whether there is a causal relationship between those two is unclear.
Our study has a number of limitations. First of all, the number of patients studied is small; however, all patients suffered from SAP and were at risk of developing organ dysfunction. The SST was performed within 5 days of admission and gives only a momentary assessment of adrenal function; episodes of decreased reactivity to ACTH may have been missed in some patients. Most importantly, the diagnosis of RAI in critically ill patients remains a complex issue, and the definitions used are probably not opti-mal. The current criterion of a change in total cortisol of less than 9 µg/dl after SST has been challenged recently, and some experts advocate adding the baseline total cortisol level to the diagnostic criteria [20] . There has also been much discussion about the problem of hypoproteinaemia that may affect the results of the SST, as more than 90% of cortisol is protein bound. Also, in our study there was a trend towards lower albumin levels in patients with RAI. However, in a recent study, Annane et al. demonstrated that the delta cortisol cut-off level of 9 µg/dl or less, or a baseline cortisol level of 10 µg/dl or lower, is a strong predictor of RAI, where a postmetapyrone serum 11-beta deoxycortisol level of 7 µg/dl or less was used as gold standard [21] .
In conclusion, we found that the incidence of RAI as described in patients with septic shock is low during the early course of the disease in patients with SAP. However, in a subset of patients with more severe disease, i. e. patients with organ dysfunction or pancreatic necrosis, more than one quarter were diagnosed with RAI. Patients with RAI were more severely ill, as demonstrated by the higher SOFA scores and 28-day mortality. The role of exogenous corticosteroids in patients with SAP deserves further attention, especially in patients with a complicated course of the disease.
